Sionna Therapeutics, Inc. (SION)
5.87
-0.19
(-3.14%)
USD |
NASDAQ |
Aug 28, 16:00
5.85
-0.02
(-0.34%)
After-Hours: 20:00
Sionna Therapeutics Research and Development Expense (Annual) : 60.26M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 60.26M |
| December 31, 2024 | 57.29M |
| Date | Value |
|---|---|
| December 31, 2023 | 40.63M |
| December 31, 2022 | 34.60M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Vertex Pharmaceuticals, Inc. | 3.754B |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Immunic, Inc. | 81.98M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Anika Therapeutics, Inc. | 25.77M |